• 1991

Company Description

OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.

OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

  • Manufacturer:

    Science and Engineering
  • Formed:

    1991
  • Company Website:

  • Company E-mail:

  • Company Address:

    1522 217th Place SE, Suite 100
    Bothell, WA
    United States
  • CEO:

    • Scott Cormack
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits